NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr | ₹218 Cr |
What is the latest Sundry Debtors ratio of NEULAND LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹316 Cr |
| Mar2024 | ₹374 Cr |
| Mar2023 | ₹362 Cr |
| Mar2022 | ₹234 Cr |
| Mar2021 | ₹218 Cr |
How is Sundry Debtors of NEULAND LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹316 Cr | -15.48 | |
| Mar2024 | ₹374 Cr | 3.25 | |
| Mar2023 | ₹362 Cr | 54.39 | |
| Mar2022 | ₹234 Cr | 7.62 | |
| Mar2021 | ₹218 Cr | - | |
Compare Sundry Debtors of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,852.4 Cr | 9.6% | 3.1% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 9.6% |
3.1% |
9.5% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses